{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:35:20Z","timestamp":1794270920511,"version":"4.9.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cross-sectional studies have shown that antidepressants (ADs) and benzodiazepines (BZDs) are commonly co-prescribed for depression, potentially increasing the risk of falls and related injuries (FRI) compared to monotherapies. However, little is known about the longitudinal dosing patterns (i.e., trajectory) of ADs and BZDs and their associated FRI risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study used group-based multi-trajectory models to identify AD-BZD trajectories among older Medicare fee-for-service beneficiaries with depression initiating ADs with\/without BZDs. We measured the standardized daily doses of AD and BZD within 84\u00a0days after AD initiation and categorized them into negligible, very-low, low, moderate, high, or very-high levels with a discontinuing, declining, increasing, or stable trend. Then, we assessed the subsequent 12-month FRI risk associated with each trajectory.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 102,750 eligible beneficiaries, the mean age was 75.5\u00a0years (SD\u2009=\u20097.5); 67.0% were female, 81.2% were White, and 4.9% experienced an FRI. We identified 12 distinct AD\/BZD trajectories, of which 79,424 patients received AD monotherapy, and 23,326 patients received both ADs and BZDs. Compared with Group A (low discontinuing AD; 17.3% of the cohort; FRI crude incidence rate\u2009=\u200999.7\/1000 person-year), trajectories with a higher dose or a longer duration of AD use were associated with an increased FRI risk, regardless of BZD use. The hazard ratios (HR) and 95% confidence intervals (CI) for Groups B (low declining AD; 31.0% of the cohort), C (moderate increasing AD; 23.5%), and D (high increasing AD; 5.4%) were 1.11 (1.04\u20131.19), 1.24 (1.16\u20131.32), and 1.29 (1.16\u20131.42), respectively. Combining ADs and BZDs at very-low doses or with declining trends did not significantly alter FRI risk compared to AD monotherapy. However, FRI risk increased when BZDs were used at low doses (either with stable or increasing trends). The HR and 95%CI for Groups J (moderate increasing AD\/low stable BZD, 1.3%) and L (very-high increasing AD\/low-dose increasing BZD) were 1.71 (1.41, 2.08) and 1.96 (1.53, 2.49), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We observed a dose\u2013response relationship between AD use and FRI risk, independent of BZD use, highlighting the importance of initiating ADs at the lowest effective dose and closely monitoring to prevent FRI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12916-025-04325-2","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T22:45:34Z","timestamp":1755643534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Longitudinal patterns of antidepressant and benzodiazepine use associated with injurious falls in older adults with depression: a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Grace Hsin-Min","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie J.","family":"Goodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Reise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald I.","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taewoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"Lo-Ciganic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"1","key":"4325_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12991-021-00375-x","volume":"20","author":"Y Zenebe","year":"2021","unstructured":"Zenebe Y, Akele B, W\/Selassie M, Necho M. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55.","journal-title":"Ann Gen Psychiatry"},{"issue":"4","key":"4325_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatr. 2018;75(4):336\u201346.","journal-title":"JAMA Psychiatr"},{"key":"4325_CR3","doi-asserted-by":"publisher","unstructured":"Ogawa Y, Takeshima N, Hayasaka Y, Tajika A, Watanabe N, Streiner D, Furukawa TA. Antidepressants plus benzodiazepines for adults with major depression. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD001026. https:\/\/doi.org\/10.1002\/14651858. CD001026.pub2. Accessed 07 Aug 2025.","DOI":"10.1002\/14651858"},{"issue":"11","key":"4325_CR4","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.4088\/JCP.10m06419","volume":"72","author":"R Uher","year":"2011","unstructured":"Uher R, Mors O, Rietschel M, Rajewska-Rager A, Petrovic A, Zobel A, et al. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. J Clin Psychiatry. 2011;72(11):5274.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"4325_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamapsychiatry.2017.1273","volume":"74","author":"GA Bushnell","year":"2017","unstructured":"Bushnell GA, St\u00fcrmer T, Gaynes BN, Pate V, Miller M. Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001\u20132014. JAMA Psychiatr. 2017;74(7):747\u201355.","journal-title":"JAMA Psychiatr"},{"issue":"3","key":"4325_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/JCP.0b013e318217b4c4","volume":"31","author":"PN Pfeiffer","year":"2011","unstructured":"Pfeiffer PN, Ganoczy D, Zivin K, Valenstein M. Benzodiazepines and adequacy of initial antidepressant treatment for depression. J Clin Psychopharmacol. 2011;31(3):360.","journal-title":"J Clin Psychopharmacol"},{"issue":"9356","key":"4325_CR7","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0140-6736(03)12502-0","volume":"361","author":"JG Evans","year":"2003","unstructured":"Evans JG. Drugs and falls in later life. Lancet. 2003;361(9356):448.","journal-title":"Lancet"},{"key":"4325_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40261-018-0721-6","volume":"39","author":"S Laberge","year":"2019","unstructured":"Laberge S, Crizzle AM. A literature review of psychotropic medications and alcohol as risk factors for falls in community dwelling older adults. Clin Drug Investig. 2019;39:117\u201339.","journal-title":"Clin Drug Investig"},{"issue":"4","key":"4325_CR9","first-page":"371","volume":"19","author":"LJ Seppala","year":"2018","unstructured":"Seppala LJ, Wermelink AM, de Vries M, Ploegmakers KJ, van de Glind EM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19(4):371 e11-. e17.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"4325_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"AGSBCUE Panel","year":"2019","unstructured":"Panel AGSBCUE, Fick DM, Semla TP, Steinman M, Beizer J, Brandt N, et al. American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"4325_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1060028016644466","volume":"50","author":"ZA Marcum","year":"2016","unstructured":"Marcum ZA, Perera S, Thorpe JM, Switzer GE, Castle NG, Strotmeyer ES, et al. Antidepressant use and recurrent falls in community-dwelling older adults: findings from the Health ABC study. Ann Pharmacother. 2016;50(7):525\u201333.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"4325_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1365-2125.2011.04124.x","volume":"73","author":"CS Sterke","year":"2012","unstructured":"Sterke CS, Ziere G, van Beeck EF, Looman CW, van der Cammen TJ. Dose\u2013response relationship between selective serotonin re-uptake inhibitors and injurious falls: a study in nursing home residents with dementia. Br J Clin Pharmacol. 2012;73(5):812\u201320.","journal-title":"Br J Clin Pharmacol"},{"issue":"9596","key":"4325_CR13","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"key":"4325_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2147\/CLEP.S105613","volume":"9","author":"KE Mues","year":"2017","unstructured":"Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, et al. Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017;9:267\u201377.","journal-title":"Clin Epidemiol"},{"key":"4325_CR15","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S105613","author":"KE Mues","year":"2017","unstructured":"Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, et al. Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017. https:\/\/doi.org\/10.2147\/CLEP.S105613.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"4325_CR16","first-page":"43","volume":"12","author":"RL Robinson","year":"2006","unstructured":"Robinson RL, Long SR, Chang S, Able S, Baser O, Obenchain R, et al. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharm. 2006;12(1):43\u201354.","journal-title":"J Manag Care Pharm"},{"key":"4325_CR17","first-page":"28","volume":"52","author":"DJ Kupfer","year":"1991","unstructured":"Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry. 1991;52:28\u201334.","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"4325_CR18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","volume":"27","author":"DS Nagin","year":"2018","unstructured":"Nagin DS, Jones BL, Passos VL, Tremblay RE. Group-based multi-trajectory modeling. Stat Med Res. 2018;27(7):2015\u201323.","journal-title":"Stat Med Res"},{"key":"4325_CR19","unstructured":"L. Jones B, Nagin D. A Stata Plugin for Estimating Group-Based Trajectory Models [Internet]. Carnegie Mellon University; 2018. Cited 2025 Aug 3. Available from: https:\/\/kilthub.cmu.edu\/articles\/journalcontribution\/A_Stata_Plugin_for_Estimating_Group-Based_Trajectory_Models\/6470963\/1"},{"issue":"1","key":"4325_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","volume":"10","author":"AM Peterson","year":"2007","unstructured":"Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10(1):3\u201312.","journal-title":"Value Health"},{"issue":"6","key":"4325_CR21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/ajhp\/zxab392","volume":"79","author":"J Loucks","year":"2022","unstructured":"Loucks J, Zuckerman AD, Berni A, Saulles A, Thomas G, Alonzo A. Proportion of days covered as a measure of medication adherence. American journal of health-system pharmacy\u202f: AJHP\u202f: official journal of the American Society of Health-System Pharmacists. 2022;79(6):492\u20136.","journal-title":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists"},{"key":"4325_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s002280050064","volume":"50","author":"J Merlo","year":"1996","unstructured":"Merlo J, Wessling A, Melander A. Comparison of dose standard units for drug utilisation studies. Eur J Clin Pharmacol. 1996;50:27\u201330.","journal-title":"Eur J Clin Pharmacol"},{"key":"4325_CR23","unstructured":"Abimbola Farinde, PharmD, PhD. Benzodiazepine Equivalency Chart: Benzodiazepine Equivalency. Medscape.com. Medscape; 2024. Cited 2025 Aug 3. Available from: https:\/\/emedicine.medscape.com\/article\/2172250-overview"},{"key":"4325_CR24","first-page":"969","volume-title":"Conn\u2019s current therapy 2016","author":"ET Bope","year":"2016","unstructured":"Bope ET, Kellerman RD, Conn HF. Conn\u2019s current therapy 2016. Philadelphia, Pa: Elsevier; 2016. p. 969\u20131004."},{"key":"4325_CR25","unstructured":"Mdcalc.com. 2023. Cited 2025 Aug 3. Available from: https:\/\/www.mdcalc.com\/calc\/10091\/benzodiazepine-conversion-calculator"},{"issue":"1","key":"4325_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-2-614","volume":"2","author":"T Weichle","year":"2013","unstructured":"Weichle T, Hynes DM, Durazo-Arvizu R, Tarlov E, Zhang Q. Impact of alternative approaches to assess outlying and influential observations on health care costs. Springerplus. 2013;2(1):1\u201311.","journal-title":"Springerplus"},{"issue":"7","key":"4325_CR27","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/add.15857","volume":"117","author":"WH Lo-Ciganic","year":"2022","unstructured":"Lo-Ciganic WH, Hincapie-Castillo J, Wang T, Ge Y, Jones BL, Huang JL, et al. Dosing profiles of concurrent opioid and benzodiazepine use associated with overdose risk among US Medicare beneficiaries: group-based multi-trajectory models. Addiction. 2022;117(7):1982\u201397.","journal-title":"Addiction"},{"key":"4325_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"key":"4325_CR29","unstructured":"WHOCC. WHOCC - ATC\/DDD Index. Whocc.no. 2019. Cited 2025 Aug 3. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/"},{"key":"4325_CR30","unstructured":"Rush J. UpToDate. Uptodate.com. 2019. Cited 2025 Aug 3. Available from: https:\/\/www.uptodate.com\/contents\/unipolar-major-depression-in-adults-choosing-initial-treatment"},{"key":"4325_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s40261-018-0648-y","volume":"38","author":"J Brandt","year":"2018","unstructured":"Brandt J, Alkabanni W, Alessi-Severini S, Leong C. Translating benzodiazepine utilization data into meaningful population exposure: integration of two metrics for improved reporting. Clin Drug Investig. 2018;38:565\u201372.","journal-title":"Clin Drug Investig"},{"key":"4325_CR32","unstructured":"Abimbola Farinde, PharmD, PhD. Benzodiazepine Equivalency Chart: Benzodiazepine Equivalency. Medscape.com. Medscape; 2024. Cited 2025 Aug 3. Available from: https:\/\/emedicine.medscape.com\/article\/2172250-overview#showall"},{"key":"4325_CR33","unstructured":"Benzodiazepine Conversion Calculator. MDCalc. 2024 Cited 2025 Aug 3. Available from: https:\/\/www.mdcalc.com\/benzodiazepine-conversion-calculator#evidence"},{"issue":"1","key":"4325_CR34","first-page":"58","volume":"28","author":"EP Borrelli","year":"2022","unstructured":"Borrelli EP, Bratberg J, Hallowell BD, Greaney ML, Kogut SJ. Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018. J Manag Care Spec Pharm. 2022;28(1):58\u201368.","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"4325_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/oxfordjournals.aje.a112408","volume":"105","author":"KT Copeland","year":"1977","unstructured":"Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105(5):488\u201395.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"4325_CR36","doi-asserted-by":"publisher","first-page":"e199679","DOI":"10.1001\/jamanetworkopen.2019.9679","volume":"2","author":"L Min","year":"2019","unstructured":"Min L, Tinetti M, Langa KM, Ha J, Alexander N, Hoffman GJ. Measurement of fall injury with health care system data and assessment of inclusiveness and validity of measurement models. JAMA Netw Open. 2019;2(8):e199679-e.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"4325_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/2042098613486829","volume":"4","author":"MR De Jong","year":"2013","unstructured":"De Jong MR, Van der Elst M, Hartholt KA. Drug-related falls in older patients: implicated drugs, consequences, and possible prevention strategies. Ther Adv Drug Saf. 2013;4(4):147\u201354.","journal-title":"Ther Adv Drug Saf"},{"issue":"9","key":"4325_CR38","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1097\/MLR.0b013e318297429c","volume":"53","author":"SR Austin","year":"2015","unstructured":"Austin SR, Wong Y-N, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson comorbidity index and Elixhauser score work. Med Care. 2015;53(9):e65.","journal-title":"Med Care"},{"issue":"1","key":"4325_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-015-0029-9","volume":"15","author":"MS Salahudeen","year":"2015","unstructured":"Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15(1):1\u201314.","journal-title":"BMC Geriatr"},{"key":"4325_CR40","doi-asserted-by":"publisher","first-page":"1\u201310","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17:1\u201310.","journal-title":"BMC Geriatr"},{"issue":"2","key":"4325_CR41","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1037\/0012-1649.44.2.422","volume":"44","author":"A Haviland","year":"2008","unstructured":"Haviland A, Nagin DS, Rosenbaum PR, Tremblay RE. Combining group-based trajectory modeling and propensity score matching for causal inferences in nonexperimental longitudinal data. Dev Psychol. 2008;44(2):422.","journal-title":"Dev Psychol"},{"issue":"1","key":"4325_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MLR.0000000000001019","volume":"57","author":"AN Winn","year":"2019","unstructured":"Winn AN, Fergestrom NM, Neuner JM. Using group based trajectory models and propensity score weighting to detect heterogeneous treatment effects: the case study of generic hormonal therapy for women with breast cancer. Med Care. 2019;57(1):85.","journal-title":"Med Care"},{"issue":"19","key":"4325_CR43","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med. 2013;32(19):3388\u2013414.","journal-title":"Stat Med"},{"issue":"8","key":"4325_CR44","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/aje\/kwab041","volume":"190","author":"T St\u00fcrmer","year":"2021","unstructured":"St\u00fcrmer T, Webster-Clark M, Lund JL, Wyss R, Ellis AR, Lunt M, et al. Propensity score weighting and trimming strategies for reducing variance and bias of treatment effect estimates: a simulation study. Am J Epidemiol. 2021;190(8):1659\u201370.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"4325_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9(2):215\u201334.","journal-title":"Int J Biostat"},{"issue":"1","key":"4325_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/0962280210386207","volume":"21","author":"ML Petersen","year":"2012","unstructured":"Petersen ML, Porter KE, Gruber S, Wang Y, Van Der Laan MJ. Diagnosing and responding to violations in the positivity assumption. Stat Med Res. 2012;21(1):31\u201354.","journal-title":"Stat Med Res"},{"issue":"3","key":"4325_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"7","key":"4325_CR48","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/aje\/kwq198","volume":"172","author":"T St\u00fcrmer","year":"2010","unstructured":"St\u00fcrmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2014a simulation study. Am J Epidemiol. 2010;172(7):843\u201354.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"4325_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12874-023-02058-5","volume":"23","author":"I Olier","year":"2023","unstructured":"Olier I, Zhan Y, Liang X, Volovici V. Causal inference and observational data. BMC Med Res Methodol. 2023;23(1):227.","journal-title":"BMC Med Res Methodol"},{"key":"4325_CR50","doi-asserted-by":"crossref","unstructured":"Normand S-LT, Landrum MB, Guadagnoli E, Ayanian JZ, Ryan TJ, Cleary PD, et al. Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol. 2001;54(4):387\u201398.","DOI":"10.1016\/S0895-4356(00)00321-8"},{"key":"4325_CR51","doi-asserted-by":"publisher","unstructured":"Kang JDY, Schafer JL. Demystifying Double Robustness: A Comparison of Alternative Strategies for Estimating a Population Mean from Incomplete Data. Stat Sci: Rev J Inst Math Stat. 2007;22(4):523\u201339. https:\/\/doi.org\/10.1214\/07-STS227.","DOI":"10.1214\/07-STS227"},{"issue":"1","key":"4325_CR52","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","volume":"69","author":"D Schoenfeld","year":"1982","unstructured":"Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69(1):239\u201341.","journal-title":"Biometrika"},{"issue":"6","key":"4325_CR53","first-page":"1120","volume":"75","author":"DH Kim","year":"2020","unstructured":"Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the US Medicare data. The Journals of Gerontology: Series A. 2020;75(6):1120\u20135.","journal-title":"The Journals of Gerontology: Series A"},{"issue":"7","key":"4325_CR54","first-page":"980","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring frailty in Medicare data: development and validation of a claims-based frailty index. The Journals of Gerontology: Series A. 2018;73(7):980\u20137.","journal-title":"The Journals of Gerontology: Series A"},{"issue":"8","key":"4325_CR55","first-page":"1271","volume":"74","author":"DH Kim","year":"2019","unstructured":"Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. The Journals of Gerontology: Series A. 2019;74(8):1271\u20136.","journal-title":"The Journals of Gerontology: Series A"},{"issue":"9","key":"4325_CR56","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.7326\/M20-7141","volume":"174","author":"DH Kim","year":"2021","unstructured":"Kim DH, Pawar A, Gagne JJ, Bessette LG, Lee H, Glynn RJ, et al. Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study. Ann Intern Med. 2021;174(9):1214\u201323.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4325_CR57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3233\/JAD-2009-1099","volume":"17","author":"DH Taylor Jr","year":"2009","unstructured":"Taylor DH Jr, \u00d8stbye T, Langa KM, Weir D, Plassman BL. The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. Journal of Alzheimer\u2019s disease\u202f: JAD. 2009;17(4):807\u201315.","journal-title":"Journal of Alzheimer's disease : JAD"},{"issue":"8","key":"4325_CR58","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1111\/jgs.17183","volume":"69","author":"LM Moura","year":"2021","unstructured":"Moura LM, Festa N, Price M, Volya M, Benson NM, Zafar S, et al. Identifying Medicare beneficiaries with dementia. J Am Geriatr Soc. 2021;69(8):2240\u201351.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"4325_CR59","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"issue":"4","key":"4325_CR60","doi-asserted-by":"publisher","first-page":"e018956","DOI":"10.1136\/bmjopen-2017-018956","volume":"8","author":"I Fulone","year":"2018","unstructured":"Fulone I, Silva MT, Lopes LC. Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study. BMJ Open. 2018;8(4):e018956.","journal-title":"BMJ Open"},{"key":"4325_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2698","volume":"350","author":"TW Park","year":"2015","unstructured":"Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ. 2015;350: h2698.","journal-title":"BMJ"},{"issue":"4","key":"4325_CR62","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/JCP.0b013e31817d5943","volume":"28","author":"JM Bolton","year":"2008","unstructured":"Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol. 2008;28(4):384\u201391.","journal-title":"J Clin Psychopharmacol"},{"key":"4325_CR63","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00198-012-2043-5","volume":"24","author":"P Vestergaard","year":"2013","unstructured":"Vestergaard P, Prieto-Alhambra D, Javaid MK, Cooper C. Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos Int. 2013;24:671\u201380.","journal-title":"Osteoporos Int"},{"key":"4325_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116109","volume":"153","author":"BR Yang","year":"2021","unstructured":"Yang BR, Lee E, Hwang BS, Lee SH, Kang Y-J, Jung S-Y. Risk of fracture in antidepressant users with concurrent use of benzodiazepines: a self-controlled case-series analysis. Bone. 2021;153: 116109.","journal-title":"Bone"},{"issue":"2","key":"4325_CR65","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7326\/0003-4819-146-2-200701160-00004","volume":"146","author":"AK Wagner","year":"2007","unstructured":"Wagner AK, Ross-Degnan D, Gurwitz JH, Zhang F, Gilden DB, Cosler L, et al. Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med. 2007;146(2):96\u2013103.","journal-title":"Ann Intern Med"},{"issue":"6","key":"4325_CR66","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1192\/bja.2020.17","volume":"26","author":"A de Cates","year":"2020","unstructured":"de Cates A, De Giorgi R. Antidepressants plus benzodiazepines in major depressive disorder: a clinical dilemma with no recent answers from research. BJPsych advances. 2020;26(6):321\u20136.","journal-title":"BJPsych advances"},{"issue":"8","key":"4325_CR67","doi-asserted-by":"publisher","first-page":"e2435535","DOI":"10.1001\/jamanetworkopen.2024.35535","volume":"7","author":"GH Wang","year":"2024","unstructured":"Wang GH, Lai EC, Goodin AJ, Reise RC, Shorr RI, Lo-Ciganic WH. Injurious fall risk differences among older adults with first-line depression treatments. JAMA Netw Open. 2024;7(8):e2435535.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"4325_CR68","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1177\/07334648211067526","volume":"41","author":"VL Chuen","year":"2022","unstructured":"Chuen VL, Chan AC, Ma J, Alibhai SM, Chau V. Assessing the accuracy of international classification of diseases (ICD) coding for delirium. J Appl Gerontol. 2022;41(5):1485\u201390.","journal-title":"J Appl Gerontol"},{"key":"4325_CR69","unstructured":"Freed M, Fuglesten Biniek J, Damico A, Neuman T. Medicare Advantage in 2024: Enrollment Update and Key Trends | KFF . KFF. 2024. Cited 2025 Aug 3. Available from: https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-advantage-in-2024-enrollment-update-and-key-trends\/"},{"key":"4325_CR70","unstructured":"Clerveau G, Ochieng N. A Snapshot of Sources of Coverage Among Medicare Beneficiaries. KFF. 2023. Cited 2025 Aug 3. Available from: https:\/\/www.kff.org\/medicare\/issue-brief\/a-snapshot-of-sources-of-coverage-among-medicare-beneficiaries\/"},{"issue":"5","key":"4325_CR71","doi-asserted-by":"publisher","first-page":"e011200","DOI":"10.1136\/bmjopen-2016-011200","volume":"6","author":"KB Leth-M\u00f8ller","year":"2016","unstructured":"Leth-M\u00f8ller KB, Hansen AH, Torstensson M, Andersen SE, \u00d8dum L, Gislasson G, et al. Antidepressants and the risk of hyponatremia: a Danish register-based population study. BMJ Open. 2016;6(5):e011200.","journal-title":"BMJ Open"},{"key":"4325_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2318-13-50","volume":"13","author":"D Klein","year":"2013","unstructured":"Klein D, Nagel G, Kleiner A, Ulmer H, Rehberger B, Concin H, et al. Blood pressure and falls in community-dwelling people aged 60 years and older in the VHM&PP cohort. BMC Geriatr. 2013;13:1\u20137.","journal-title":"BMC Geriatr"},{"key":"4325_CR73","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpw129","author":"C Finucane","year":"2016","unstructured":"Finucane C, Kenny RA. Falls risk, orthostatic hypotension, and optimum blood pressure management: is it all in our heads? Am J Hypertens. 2016. https:\/\/doi.org\/10.1093\/ajh\/hpw129.","journal-title":"Am J Hypertens"},{"key":"4325_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168257","author":"AA Abu Bakar","year":"2021","unstructured":"Abu Bakar AA, Abdul Kadir A, Idris NS, Mohd Nawi SN. Older adults with hypertension: prevalence of falls and their associated factors. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18168257.","journal-title":"Int J Environ Res Public Health"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04325-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04325-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T17:16:31Z","timestamp":1757438191000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04325-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4325"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04325-2","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Per Centers for Medicare & Medicaid Services (CMS) policy, informed consent is not required for research involving limited datasets, provided the use complies with the CMS Data Use Agreement (DUA) and all applicable privacy and security requirements. The study used limited datasets including dates of diagnosis, prescriptions, and healthcare utilization. This research was conducted under an approved DUA (RSCH-2024\u201370191), and the University of Florida Institutional Review Board (IRB202301515) granted a waiver of informed consent consistent with Health Insurance Portability and Accountability Act (HIPAA) provisions for secondary research using de-identified or limited datasets.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}